Search Results

You are looking at 1 - 2 of 2 items for

  • Author: Rebecca Oelkrug x
  • Refine by Access: All content x
Clear All Modify Search
K Alexander Iwen Medizinische Klinik I, Experimentelle und Klinische Endokrinologie, Universität zu Lübeck, Lübeck, Germany
Department of Molecular Endocrinology, Center of Brain, Behavior and Metabolism, Universität zu Lübeck, Lübeck, Germany

Search for other papers by K Alexander Iwen in
Google Scholar
PubMed
Close
,
Rebecca Oelkrug Department of Molecular Endocrinology, Center of Brain, Behavior and Metabolism, Universität zu Lübeck, Lübeck, Germany

Search for other papers by Rebecca Oelkrug in
Google Scholar
PubMed
Close
, and
Georg Brabant Medizinische Klinik I, Experimentelle und Klinische Endokrinologie, Universität zu Lübeck, Lübeck, Germany
Department of Endocrinology, The Christie Manchester Academic Health Science Centre, Manchester, UK

Search for other papers by Georg Brabant in
Google Scholar
PubMed
Close

Thyroid hormones (TH) are of central importance for thermogenesis, energy homeostasis and metabolism. Here, we will discuss these aspects by focussing on the physiological aspects of TH-dependent regulation in response to cold exposure and fasting, which will be compared to alterations in primary hyperthyroidism and hypothyroidism. In particular, we will summarise current knowledge on regional thyroid hormone status in the central nervous system (CNS) and in peripheral cells. In contrast to hyperthyroidism and hypothyroidism, where parallel changes are observed, local alterations in the CNS differ to peripheral compartments when induced by cold exposure or fasting. Cold exposure is associated with low hypothalamic TH concentrations but increased TH levels in the periphery. Fasting results in a reversed TH pattern. Primary hypothyroidism and hyperthyroidism disrupt these fine-tuned adaptive mechanisms and both, the hypothalamus and the periphery, will have the same TH status. These important mechanisms need to be considered when discussing thyroid hormone replacement and other therapeutical interventions to modulate TH status.

Free access
Sogol Gachkar Molecular Endocrinology, Medical Department I, University of Lübeck, Lübeck, Germany

Search for other papers by Sogol Gachkar in
Google Scholar
PubMed
Close
,
Sebastian Nock Molecular Endocrinology, Medical Department I, University of Lübeck, Lübeck, Germany

Search for other papers by Sebastian Nock in
Google Scholar
PubMed
Close
,
Cathleen Geissler Epigenetics & Metabolism, Medical Department I, University of Lübeck, Lübeck, Germany

Search for other papers by Cathleen Geissler in
Google Scholar
PubMed
Close
,
Rebecca Oelkrug Molecular Endocrinology, Medical Department I, University of Lübeck, Lübeck, Germany

Search for other papers by Rebecca Oelkrug in
Google Scholar
PubMed
Close
,
Kornelia Johann Molecular Endocrinology, Medical Department I, University of Lübeck, Lübeck, Germany

Search for other papers by Kornelia Johann in
Google Scholar
PubMed
Close
,
Julia Resch Molecular Endocrinology, Medical Department I, University of Lübeck, Lübeck, Germany

Search for other papers by Julia Resch in
Google Scholar
PubMed
Close
,
Awahan Rahman Department for Comparative Medicine, Karolinska Institutet, Stockholm, Sweden

Search for other papers by Awahan Rahman in
Google Scholar
PubMed
Close
,
Anders Arner Department of Cardiothoracic Surgery, Clinical Sciences Lund, Lund University, Lund, Sweden

Search for other papers by Anders Arner in
Google Scholar
PubMed
Close
,
Henriette Kirchner Epigenetics & Metabolism, Medical Department I, University of Lübeck, Lübeck, Germany

Search for other papers by Henriette Kirchner in
Google Scholar
PubMed
Close
, and
Jens Mittag Molecular Endocrinology, Medical Department I, University of Lübeck, Lübeck, Germany

Search for other papers by Jens Mittag in
Google Scholar
PubMed
Close

It is well established that thyroid hormones are required for cardiovascular functions; however, the molecular mechanisms remain incompletely understood, especially the individual contributions of genomic and non-genomic signalling pathways. In this study, we dissected how thyroid hormones modulate aortic contractility. To test the immediate effects of thyroid hormones on vasocontractility, we used a wire myograph to record the contractile response of dissected mouse aortas to the adrenergic agonist phenylephrine in the presence of different doses of T3 (3,3′,5-triiodothyronine). Interestingly, we observed reduced vasoconstriction under low and high T3 concentrations, indicating an inversed U-shaped curve with maximal constrictive capacity at euthyroid conditions. We then tested for possible genomic actions of thyroid hormones on vasocontractility by treating mice for 4 days with 1 mg/L thyroxine in drinking water. The study revealed that in contrast to the non-genomic actions the aortas of these animals were hyperresponsive to the contractile stimulus, an effect not observed in endogenously hyperthyroid TRβ knockout mice. To identify targets of genomic thyroid hormone action, we analysed aortic gene expression by microarray, revealing several altered genes including the well-known thyroid hormone target gene hairless. Taken together, the findings demonstrate that thyroid hormones regulate aortic tone through genomic and non-genomic actions, although genomic actions seem to prevail in vivo. Moreover, we identified several novel thyroid hormone target genes that could provide a better understanding of the molecular changes occurring in the hyperthyroid aorta.

Free access